Sponsored by:

Canadian agency OKs restart of Chalk River reactor

Jul 6, 2010

The Canadian Nuclear Safety Commission today gave its approval to Atomic Energy of Canada to restart its National Research Universal reactor in Chalk River, Ontario. Operations are expected to resume by the end of the month.

Click here to read the rest of the article.

Latest in Nuclear Medicine
Isotopes
International Isotopes posts Q2 revenue increase
August 13, 2025
Isotope
DOE, state of Missouri, University of Missouri to collaborate
August 11, 2025
Your faster way to answers with Symbia Pro.specta
Sponsored
Your faster way to answers with Symbia Pro.specta
August 1, 2025
New H3 Tracers Thumbnail
SNMMI: New PET tracers developed for imaging brain disorders
June 21, 2025
Related Stories
2010 06 29 14 19 10 705 Fdgpet Landau 70
Nuclear Medicine
FDG-PET and memory tests best predict Alzheimer's
2010 06 22 10 57 01 471 Walter Sarcoma Slide11 Thumb
Nuclear Medicine
FDG-PET/CT a good option for imaging pediatric osteosarcoma
2010 06 17 13 30 57 137 Draper Slide 13 Petct Thumb
Nuclear Medicine
F-18 NaF PET/CT helps detect source of patellofemoral knee pain
Your faster way to answers with Symbia Pro.specta
Sponsor Content
Your faster way to answers with Symbia Pro.specta
More in Nuclear Medicine
International Isotopes posts Q2 revenue increase
By AuntMinnie.com staff writers
The increase was partially due to the remedying of the global shortage of cobalt-57 isotope.
August 13, 2025
Isotopes
DOE, state of Missouri, University of Missouri to collaborate
By AuntMinnie.com staff writers
Funding raised in the partnership will support a new radioisotope development center at Discovery Ridge in Columbia.
August 11, 2025
Isotope
GT Medical Technologies secures $53M in funding
By AuntMinnie.com staff writers
Medical device developer GT Medical Technologies has secured $53 million in financing.
July 15, 2025
Research Money
SNMMI: New PET tracers developed for imaging brain disorders
By Will Morton
Two newly developed PET imaging agents are effective for identifying a highly expressed receptor in neurological and psychiatric conditions.
June 21, 2025
New H3 Tracers Thumbnail
Ratio Therapeutics partners with Macrocyclics
By AuntMinnie.com staff writers
The agreement will enable access to Macropa in Japan, Canada, Australia, and a majority of Europe, according to Ratio.
June 13, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
Positrigo closes $8.5M funding round
By AuntMinnie.com staff writers
Firm also notes board changes.
June 10, 2025
Money Pile 400
Radium-223 safety confirmed in long-term study
By Erik L. Ridley
At ASCO 2025, researchers shared data on the long-term safety of Ra-223 treatments for metastatic castration-resistant prostate cancer.
June 2, 2025
Pxl 20250531 175048475~2
Clarity highlights first patient imaged in Amplify trial
By AuntMinnie.com staff writers
Clarity Pharmaceuticals has imaged the first patient in its phase III Amplify trial at XCancer in Omaha, NE.
May 29, 2025
Prostate Cancer 3 D Rendering 400 (1)
ITM forges $263M debt financing agreement
By AuntMinnie.com staff writers
Isotope Technologies Munich (ITM) has entered into a debt financing agreement for up to $262.5 million.
May 28, 2025
Isotopes1
ISMRM: AI spots ischemic heart disease on low GBCA dose images
By Erik L. Ridley
An AI-based framework was highly accurate for detecting myocardial ischemia, even on images acquired with 90% less gadolinium.
May 14, 2025
Representative stress perfusion CMR case with 80% contrast dose reduction. Pixel-wise MBF maps and AHA 16-segment bull's eye plots are shown for full-dose and reduced-dose acquisitions. When analyzed using the proposed MST deep learning method, the reduced-dose data closely matches the full-dose data across basal, mid, and apical slices. In contrast, Fermi-deconvolution shows good agreement in apical and mid slices but overestimates MBF in some basal segments, indicating reduced accuracy under low-dose conditions. Image courtesy of the ISMRM.
FDA clears GE's new dual-head SPECT/CT system
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has cleared GE HealthCare's (GEHC) new dual-head SPECT/CT system, Aurora.
May 5, 2025
Gehc
Controversy clouds nuclear medicine bill
By Will Morton
Radiology societies and patient advocates are at odds over a bill in the U.S. Congress.
May 1, 2025
Congress
Page 1 of 438
Next Page